Studies on the effects of vasodilating agents in addition to volume therapy in endotoxic shock.
D000818:Animals; D003911:Dextrans / Q000627:therapeutic use; D004731:Endotoxins / Q000494:pharmacology; D004926:Escherichia coli; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005292:Ferricyanides / Q000627:therapeutic use*; D005440:Fluid Therapy; D005990:Glycerol / Q000097:blood; D008297:Male; D009599:Nitroprusside / Q000627:therapeutic use*; D011817:Rabbits; D012772:Shock, Septic / Q000188:drug therapy / Q000628:therapy*; D014280:Triglycerides / Q000097:blood
D003911:Dextrans; D004731:Endotoxins; D005230:Fatty Acids, Nonesterified; D005292:Ferricyanides; D014280:Triglycerides; D009599:Nitroprusside; D005990:Glycerol